Mode
Text Size
Log in / Sign up

Systematic review finds limited evidence for antibiotics in low back pain with Modic changesAntibiotics Might Ease Back Pain for Some

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider antibiotics only for select patients with Modic type 1 changes and disc herniation, noting low-certainty evidence and increased adverse events.

This systematic review analyzed 3 randomized controlled trials involving 402 adults with low back pain, radicular pain, or both. The trials, conducted in Denmark, Belgium, and Norway, compared oral antibiotic therapy (amoxicillin–clavulanate, amoxicillin, or minocycline) against placebo or amitriptyline. The review specifically assessed four patient populations based on the presence of Modic changes and disc herniation.

In the population with Modic type 1 changes and disc herniation, amoxicillin showed a mean difference of -8.42 points (95% CI -16.18 to -0.67) on a 0-100 back pain scale and -10.52 points (95% CI -15.94 to -5.09) on a 0-100 disability scale at 12-14 weeks, favoring the antibiotic. The effects were described as slight to small for pain and small to moderate for disability. No trials were identified for patients with any Modic changes but no disc herniation, and effects for other populations were uncertain.

Safety data showed 76 of every 100 people taking amoxicillin reported adverse events versus 49 of every 100 taking placebo (RR 1.79, 95% CI 0.54 to 5.94). Serious adverse events were reported in 3 of every 100 taking amoxicillin versus 2 of every 100 taking placebo (RR 1.43, 95% CI 0.11 to 18.35). The review had no dedicated funding.

Key limitations include the low to very low overall certainty of evidence, downgraded for imprecision and indirectness. The findings are based on a small total sample size and only apply to a specific subset of patients. For clinical practice, the potential slight benefits in a narrow patient population must be weighed against the increased likelihood of adverse events and the very uncertain evidence regarding serious harms.

Imagine waking up with a back so stiff you can barely stand. You try heat, rest, and even painkillers, but the ache just won't go away. Now picture a scan showing a specific signal change in your spine. Could a simple antibiotic be the missing key?

Low back pain is the number one cause of disability around the world. It keeps people from working, playing with kids, and enjoying life.

Doctors have long noticed a pattern on MRI scans. These images show signal changes in the endplate of the vertebrae. These spots are called Modic changes. Some experts think these changes might be caused by a hidden infection.

If that theory is true, antibiotics could treat the root cause instead of just masking the pain. But for years, doctors have been unsure if this approach actually works for patients.

The surprising shift

For a long time, the standard advice was to avoid antibiotics for back pain. The thinking was that the pain wasn't caused by bacteria.

But here is the twist. New research suggests that for a specific group of people, antibiotics might help. This group has low back pain, a condition called disc herniation, and a specific type of signal change known as Modic type 1.

What scientists didn't expect

To understand the science, imagine your spine has a lock and key system. In a healthy spine, the lock fits perfectly. In some cases, the lock gets swollen and inflamed. This swelling is called edema.

Researchers suspected that bacteria might be causing this swelling. If true, an antibiotic would act like a key to clear out the infection and let the spine heal.

Scientists looked at three major studies from Denmark, Belgium, and Norway. Together, these studies followed 402 adults.

The participants had moderate to severe back pain lasting more than six months. They all had the specific MRI changes mentioned above.

Some took amoxicillin, an antibiotic. Others took a placebo, which looks like a pill but has no medicine in it. One small study also tested a different antibiotic called minocycline.

The results were mixed but promising for the right patients. People taking amoxicillin reported slightly less pain after 12 to 14 weeks.

Their average pain score dropped by about 8 points on a scale of 100. Their disability scores also improved by about 10 points.

This means they could move more easily and do daily tasks with less struggle.

But there's a catch

The benefits were small. They were not a miracle cure. The pain relief was modest compared to the placebo.

Also, the evidence is not perfect. The studies were small, and the results varied. Scientists say we cannot be 100% sure yet.

This doesn't mean this treatment is available yet.

Doctors need more data before recommending this as a standard option. Right now, it is only a possibility for specific cases.

If you have chronic back pain and have had an MRI, ask your doctor about your specific scan results. Do you have Modic type 1 changes? Do you also have a disc herniation?

If the answer is yes, talk to your doctor about whether an antibiotic trial makes sense for you.

However, do not start taking antibiotics on your own. These medicines can cause side effects like stomach upset or yeast infections. They also contribute to antibiotic resistance, which is a serious global health issue.

More research is needed to confirm these findings. Scientists want to know if the benefits last longer than 14 weeks. They also need to know more about the risks of side effects.

Until then, the best approach remains a mix of physical therapy, staying active, and standard pain management. Antibiotics might be one tool in the toolbox, but they are not the only solution.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Rationale Low back pain is the leading cause of disability worldwide. Research has associated Modic changes (signal changes in the vertebral endplate on magnetic resonance imaging (MRI)) with low back pain. Some hypothesise that Modic type 1 changes (oedema) may have an infective cause, and that antibiotics could serve as targeted treatment. Objectives To assess the benefits and harms of antibiotic therapy, compared with placebo or another treatment, in people with low back pain, radicular pain, or both. Search methods We searched CENTRAL, MEDLINE, Embase, and two trials registries up to 26 August 2025, with no restrictions related to language or date of publication. Eligibility criteria We included randomised controlled trials (RCTs) that assessed antibiotics versus placebo (primary comparison) or other treatments. We assessed the evidence separately for four populations of adults with low back pain, radicular pain, or both: those with 1) Modic type 1 changes and evidence of disc herniation, 2) other Modic changes and evidence of disc herniation, 3) any Modic changes but no evidence of disc herniation, and 4) evidence of disc herniation without any Modic changes. Outcomes Critical outcomes were pain intensity and disability or function up to 12 to 14 weeks, and the number of participants with any adverse events and serious adverse events at the end of the trial period. Risk of bias Two review authors independently evaluated the risk of bias using the Cochrane risk of bias tool RoB 1. Synthesis methods Two review authors independently screened studies and extracted data. We synthesised results for each outcome using random‐effects meta‐analysis. Where this was not possible due to the nature of the data, we reported the results descriptively. We used GRADE to assess the certainty of evidence. The primary comparison was antibiotics versus placebo in people with low back pain, radicular pain, or both, and Modic type 1 changes with evidence of disc herniation (population 1) up to 12 to 14 weeks. Included studies We included three trials, conducted in Denmark, Belgium, and Norway, with a total of 402 participants (mean ages ranged from 44.7 years to 51.0 years). Two trials recruited people with chronic (> 6 months) moderate‐to‐severe low back pain (with or without radicular pain), Modic changes, and disc herniation. One trial included people with Modic type 1 changes only (population 1) and compared oral amoxicillin–clavulanate 500 mg/125 mg to placebo (for both treatments, 1 or 2 tablets 3 times daily for 100 days). The second trial included people with either Modic type 1 changes (population 1) or Modic type 2 changes (population 2) and compared oral amoxicillin 750 mg to placebo (for both treatments, 3 times daily for 100 days). Follow‐up was 12 months in both trials. The third trial recruited people with lumbar radicular pain (with or without low back pain) and disc herniation. Modic changes was not an inclusion criterion (population 4). This trial evaluated minocycline 100 mg versus amitriptyline 25 mg versus placebo and followed participants for 14 days (treatment duration). There were no trials with population 3. Synthesis of results All three trials were at low risk of selection, performance, and detection bias. We rated one trial at high risk of attrition bias and unclear risk of reporting and other bias. The overall certainty of evidence is low to very low, primarily due to imprecision and indirectness. In people with low back pain, Modic type 1 changes, and disc herniation, the antibiotic oral amoxicillin (with or without clavulanate) may improve pain slightly and may result in a small to moderate improvement in disability at 12 to 14 weeks compared with placebo (low‐certainty evidence, downgraded for imprecision and indirectness). At this time point, the mean back pain score was 50.6/100 (where a lower score indicates less pain) in the amoxicillin group versus 59/100 in the placebo group (mean difference (MD) −8.42 points, 95% CI −16.18 to −0.67; I² = 35%; 2 trials, 255 participants), and the mean disability score was 45.2/100 (where a lower score indicates less disability) in the amoxicillin group versus 55.7/100 in the placebo group (MD −10.52 points, 95% CI −15.94 to −5.09; I² = 0%; 2 trials, 255 participants). We are unsure if amoxicillin (with or without clavulanate) results in more people reporting adverse events (very low‐certainty evidence, downgraded for imprecision, inconsistency, and indirectness). Adverse events were reported in 76 of every 100 people taking amoxicillin compared with 49 of every 100 people taking placebo (risk ratio (RR) 1.79, 95% CI 0.54 to 5.94; I² = 96%; 2 trials, 262 participants). We are unsure if amoxicillin (with or without clavulanate) results in more people reporting serious adverse events (very low‐certainty evidence, downgraded for imprecision and indirectness). Serious adverse events were reported in three of every 100 people taking amoxicillin (with or without clavulanate) compared with two of every 100 people taking placebo (RR 1.43, 95% CI 0.11 to 18.35; I² = 45%; 2 trials, 262 participants). We are unsure of the effects of amoxicillin compared to placebo in people with low back pain, Modic type 2 change, and disc herniation. Similarly, we are unsure of the effects of minocycline compared to placebo or amitriptyline in people with low back pain, disc herniation, and no Modic changes. Authors' conclusions In people with low back pain, Modic type 1 changes, and evidence of disc herniation, the antibiotic amoxicillin (with or without clavulanate) may provide slight to small benefits in reducing back pain and small to moderate benefits in improving disability compared to placebo at 12 to 14 weeks. The evidence on the risk of adverse events, including serious adverse events, with amoxicillin (with or without clavulanate) is very uncertain. Further research is likely to change our confidence in the estimates. Funding This review had no dedicated funding. Registration Protocol (2021): DOI 10.1002/14651858.CD014221 PICOs PICOs Population Intervention Comparison Outcome
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.